18 results
8-K
EX-99.1
OM
Outset Medical Inc
6 May 24
Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance
8:10am
. “Today’s announcement underscores Outset Medical's commitment to innovation and our ongoing dedication to transforming the landscape of dialysis
8-K
EX-99.1
OM
Outset Medical Inc
4 May 22
Outset Medical Reports First Quarter 2022 Financial Results
4:23pm
in innovation, and deliver consistent and predictable financial and operational results, increasing our confidence for sustained strong performance through
8-K
EX-99.2
OM
Outset Medical Inc
16 Feb 22
Outset Medical Reports Fourth Quarter and Full Year 2021 Financial Results
4:36pm
): 1–12. 7
Complicated Burdensome Inflexible Expensive labor and supplies Operational inefficiency Low adoption and retention at home Innovation … to the patient’s prescription Anyone Sensors, data analytics and a touchscreen interface make Tablo easy to learn and use 9
Broad technology innovation drives
424B4
4vzufx11a 2xj3ga4
9 Apr 21
Prospectus supplement with pricing info
8:42pm
DRS
d6l6ykv7 7b69ylc
25 Mar 21
Draft registration statement
12:00am
10-K
vg4j 4nz8zort6ncdyx
22 Mar 21
Annual report
4:01pm
424B4
wfy2ixpqddgj
3 Dec 20
Prospectus supplement with pricing info
4:05pm
DRS
iv0fmksbnigl
19 Nov 20
Draft registration statement
12:00am
10-Q
jv1igybpu1tkxez8
12 Nov 20
Quarterly report
8:01am
8-K
EX-99.2
wx9s37gr2nh9j9j4pxi
12 Nov 20
Outset Medical Reports Third Quarter 2020 Financial Results
7:45am
424B4
z3wr gexwiyvcu7
16 Sep 20
Prospectus supplement with pricing info
2:05pm
S-1
q3alql8fxafvfnf
21 Aug 20
IPO registration
12:46pm
DRS
u1gkky3wt
1 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next